Validation of the CAMD score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy

Researchers previously developed a scoring system to determine risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection, based on presence of cirrhosis and diabetes and patient age and male gender (called CAMD scoring system). We validated the CAMD scoring system and compared its performance with that of other risk assessment models in an independent cohort.

Source: Clinical Gastroenterology and Hepatology - June 24, 2019 Category: Gastroenterology Authors: Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Hwa Kim, Ha Yan Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Source Type: research